|
1
|
Davies B, Miles DW, Happerfield LC, Naylor
MS, Bobrow LG, Rubens RD and Balkwill FR: Activity of type IV
collagenases in benign and malignant breast disease. Br J Cancer.
67:1126–1131. 1993.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Greaney ML, Sprunck-Harrild K, Ruddy KJ,
Ligibel J, Barry WT, Baker E, Meyer M, Emmons KM and Partridge AH:
Study protocol for Young & Strong: A cluster randomized design
to increase attention to unique issues faced by young women with
newly diagnosed breast cancer. BMC Public Health.
15(37)2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Villarreal-Garza C, Aguila C,
Magallanes-Hoyos MC, Mohar A, Bargalló E, Meneses A, Cazap E, Gomez
H, López-Carrillo L, et al: Breast cancer in young women in Latin
America: An unmet, growing burden. Oncologist. 18:26–34.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Knaul F, Bustreo F, Ha E and Langer A:
Breast cancer: why link early detection to reproductive health
interventions in developing countries? Salud Publica Mex.
51:220–227. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Faghihloo E, Saremi MR, Mahabadi M, Akbari
H and Saberfar E: Prevalence and characteristics of Epstein-Barr
virus-associated gastric cancer in Iran. Arch Iran Med. 17:767–770.
2014.PubMed/NCBI
|
|
6
|
Mirzaei H, Goudarzi H, Eslami G and
Faghihloo E: Role of viruses in gastrointestinal cancer. J Cell
Physiol. 233:4000–4014. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pormohammad A, Azimi T, Falah F and
Faghihloo E: Relationship of human herpes virus 6 and multiple
sclerosis: A systematic review and meta-analysis. J Cell Physiol.
233:2850–2862. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vaezjalali M, Rashidpour S, Rezaee H,
Hajibeigi B, Zeidi M, Gachkar L, Aghamohamad S, Najafi R and
Goudarzi H: Hepatitis B viral DNA among HBs antigen negative
healthy blood donors. Hepat Mon. 13(e6590)2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lai EC: microRNAs: Runts of the genome
assert themselves. Curr Biol. 13:R925–R936. 2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: Bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36.
2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tavakolian S, Goudarzi H, Eslami G and
Faghihloo E: Transcriptional regulation of epithelial to
mesenchymal transition related genes by lipopolysaccharide in human
cervical cancer cell line HeLa. Asian Pac J Cancer Prev.
20:2455–2461. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et
al: A MicroRNA signature associated with prognosis and progression
in chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801.
2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Pourbagheri-Sigaroodi A, Bashash D,
Safaroghli-Azar A, Farshi-Paraasghari M, Momeny M, Mansoor FN and
Ghaffari SH: Contributory role of microRNAs in anti-cancer effects
of small molecule inhibitor of telomerase (BIBR1532) on acute
promyelocytic leukemia cell line. Eur J Pharmacol. 846:49–62.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12(697)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ortiz IMDP, Barros-Filho MC, Dos Reis MB,
Beltrami CM, Marchi FA, Kuasne H, do Canto LM, de Mello JBH,
Abildgaard C, Pinto CAL, et al: Loss of DNA methylation is related
to increased expression of miR-21 and miR-146b in papillary thyroid
carcinoma. Clin Epigenetics. 10(144)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Botla SK, Savant S, Jandaghi P, Bauer AS,
Mücke O, Moskalev EA, Neoptolemos JP, Costello E, Greenhalf W,
Scarpa A, et al: Early epigenetic downregulation of microRNA-192
expression promotes pancreatic cancer progression. Cancer Res.
76:4149–4159. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-ΔΔ C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Faghihloo E, Sadeghizadeh M, Shahmahmoodi
S and Mokhtari-Azad T: Cdc6 expression is induced by HPV16 E6 and
E7 oncogenes and represses E-cadherin expression. Cancer Gene Ther.
Nov 11. 2016.doi.org/10.1038/cgt.2016.51. PubMed/NCBI View Article : Google Scholar
|
|
19
|
Orangi E and Motovali-Bashi M: Evaluation
of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of
breast cancer in Iranian women. Gene. 687:272–279. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hasanzadeh A, Mesrian Tanha H, Ghaedi K
and Madani M: Aberrant expression of miR-9 in benign and malignant
breast tumors. Mol Cell Probes. 30:279–284. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Luo H, Zhang H, Zhang Z, Zhang X, Ning B,
Guo J, Nie N, Liu B and Wu X: Down-regulated miR-9 and miR-433 in
human gastric carcinoma. J Exp Clin Cancer Res.
28(82)2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W,
Tamboli P, Wood CG and Wu X: Hsa-miR-9 methylation status is
associated with cancer development and metastatic recurrence in
patients with clear cell renal cell carcinoma. Oncogene.
29:5724–5728. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cheng CW, Yu JC, Hsieh YH, Liao WL, Shieh
JC, Yao CC, Lee HJ, Chen PM, Wu PE and Shen CY: Increased cellular
levels of microRNA-9 and microRNA-221 correlate with cancer
stemness and predict poor outcome in human breast cancer. Cell
Physiol Biochem. 48:2205–2218. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Liu DZ, Chang B, Li XD, Zhang QH and Zou
YH: MicroRNA-9 promotes the proliferation, migration, and invasion
of breast cancer cells via down-regulating FOXO1. Clin Transl
Oncol. 19:1133–1140. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jang MH, Kim HJ, Gwak JM, Chung YR and
Park SY: Prognostic value of microRNA-9 and microRNA-155 expression
in triple-negative breast cancer. Hum Pathol. 68:69–78.
2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhou X, Marian C, Makambi KH, Kosti O,
Kallakury BV, Loffredo CA and Zheng YL: MicroRNA-9 as potential
biomarker for breast cancer local recurrence and tumor estrogen
receptor status. PLoS One. 7(e39011)2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Filipska M, Skrzypski M, Czetyrbok K,
Stokowy T, Stasiłojć G, Supernat A, Jassem J, Żaczek AJ and Bigda
J: MiR-192 and miR-662 enhance chemoresistance and invasiveness of
squamous cell lung carcinoma. Lung Cancer. 118:111–118.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chen ZJ, Yan YJ, Shen H, Zhou JJ, Yang GH,
Liao YX, Zeng JM and Yang T: miR-192 is overexpressed and promotes
cell proliferation in prostate cancer. Med Princ Pract. 28:124–132.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang Y, Jia LS, Yuan W, Wu Z, Wang HB, Xu
T, Sun JC, Cheng KF and Shi JG: Low miR-34a and miR-192 are
associated with unfavorable prognosis in patients suffering from
osteosarcoma. Am J Transl Res. 7:111–119. 2015.PubMed/NCBI
|
|
31
|
Hu F, Meng X, Tong Q, Liang L, Xiang R,
Zhu T and Yang S: BMP-6 inhibits cell proliferation by targeting
microRNA-192 in breast cancer. Biochim Biophys Acta.
1832:2379–2390. 2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li P, Ou Q, Braciak TA, Chen G and Oduncu
FS: MicroRNA-192-5p is a predictive biomarker of survival for Stage
IIIB colon cancer patients. Jpn J Clin Oncol. 48:619–624.
2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shang G, Mi Y, Mei Y, Wang G, Wang Y, Li
X, Wang Y, Li Y and Zhao G: MicroRNA-192 inhibits the
proliferation, migration and invasion of osteosarcoma cells and
promotes apoptosis by targeting matrix metalloproteinase-11. Oncol
Lett. 15:7265–7272. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Feng S, Cong S, Zhang X, Bao X, Wang W, Li
H, Wang Z, Wang G, Xu J, Du B, et al: MicroRNA-192 targeting
retinoblastoma 1 inhibits cell proliferation and induces cell
apoptosis in lung cancer cells. Nucleic Acids Res. 39:6669–6678.
2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lian J, Jing Y, Dong Q, Huan L, Chen D,
Bao C, Wang Q, Zhao F, Li J, Yao M, et al: miR-192, a prognostic
indicator, targets the SLC39A6/SNAIL pathway to reduce tumor
metastasis in human hepatocellular carcinoma. Oncotarget.
7:2672–2683. 2016.PubMed/NCBI View Article : Google Scholar
|
